Daily SPAC Update – April 6, 2026

by | Apr 6, 2026

Idea Acquisition, Proem Acquisition, Willow Lane II Separate Trading. Hennessy Capital Investment VII Investor Deck.

SPAC IPO UPDATE

SPAC IPO Count

Monthly IPOs (last 13 months)
Latest: 0Prior: 11MoM: -11
12
Apr ’25
22
May ’25
10
Jun ’25
13
Jul ’25
8
Aug ’25
14
Sep ’25
14
Oct ’25
10
Nov ’25
22
Dec ’25
24
Jan ’26
27Peak
Feb ’26
11
Mar ’26
0
Apr ’26
Source: Boardroom Alpha
 
[PUT IPO NARRATIVE HERE]
 
New SPAC IPOs
DateTickerIssuerIPO Size
Mar 31KPETKPET Ultra Paceline Corp$200M
Mar 27FMACFUTURE MONEY ACQUISITION CORP$100M  $12M overallotment
Mar 27IPFXINFLECTION POINT ACQUISITION CORP VI$220M  $33M overallotment
Mar 27QADRQDRO Acquisition Corp.$200M
Source: Boardroom Alpha

DAILY SPAC UPDATE

SEPARATE WARRANTS/RIGHTS
Apr 06: IDEA ACQUISITION CORP (IACO)
Apr 06: PROEM ACQUISITION CORP I (PAAC)
Apr 06: WILLOW LANE ACQUISITION CORP II (WLII)

OTHER SPAC NEWS
HVII – HENNESSY CAPITAL INVESTMENT CORP VII * Investor Deck
CRAC – CROWN RESERVE ACQUISITION CORP I * Merger Agreement

SPAC MOVERS

YESTERDAY’S TOP SPAC GAINERS
CompanyTickerChangePriceStage
HORIZON SPACE ACQUISITION II CORPHSPT 8.0%$ 5.96Announced
VOYAGER ACQUISITION CORPVACH 6.0%$ 12.33Announced
AIMEI HEALTH TECHNOLOGY CO LTDAFJK 3.8%$ 25.42Announced
GLOBA TERRA ACQUISITION CORPGTER 0.8%$ 10.29Pre-Deal
LIVE OAK ACQUISITION CORP VLOKV 0.8%$ 10.44Announced
 
YESTERDAY’S TOP SPAC LOSERS
CompanyTickerChangePriceStage
STONEBRIDGE ACQUISITION II CORPAPAC -3.3%$ 11.21Pre-Deal
HAYMAKER ACQUISITION CORP 4HYAC -3.1%$ 11.09Announced
ASPAC III ACQUISITION CORPASPC -1.7%$ 10.77Announced
AMERICAN EXCEPTIONALISM ACQUISITION CORP AAEXA -1.5%$ 10.93Pre-Deal
CANTOR EQUITY PARTNERS II INCCEPT -0.6%$ 10.98Announced
Source: Boardroom Alpha market data

Recent Analysis

Daily SPAC Update – April 3, 2026

Alphatime Extension Approved. Technology & Telecommunication Deal with Super Apps Approved. Horizon Space Sets Extension Vote. Idea, Proem and Willow Lanes Separate Trading.

Daily SPAC Update – April 2, 2026

Everest Consolidator Wants to Withdraw Interest. Spartacus Acquisition II Separate Trading Today. Hall Chadwick Non-Binding LOI with REEcycle.

Daily SPAC Update – April 1, 2026

VCIC DeSPACs to CoinShares (CSHR). Crown Reserve Deal with Carvix Announced. Sim Acquisition Extension Vote Set. SPAC Late 10-K Filings Pile Up.

Daily SPAC Update – March 30, 2026

Vine Hill + CoinShares Deal Approved. Super Apps + Technology & Telecommunication Acq Deal Vote. Cambridge and Hennessy Capital VIII Separate Trading.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.